ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator ...

Background and Aim:To compare quadruple-phase multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) for the assessment of focal and diffuse liver disease. Conclusions:MRI is ...

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring These thresholds ...

WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ANN ARBOR, ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Scopics Announces New FDA Clearance for Hepatoscope® Expanding management of Liver disease complications. Company to exhibit at DDW 2026 Chicago.

A form of MRI technology can quantify liver response in patients with nonalcoholic steatohepatitis, according to recent research by the University of California San Diego School of Medicine. Here’s ...

I stared at the MRI scan on my computer screen with a mixture of alarm and disbelief. The large pink swathes coating my ...